Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9M Sell
103,600
-28,300
-21% -$3.84M ﹤0.01% 2840
2025
Q4
$15M Buy
131,900
+3,300
+3% +$401K ﹤0.01% 2879
2025
Q3
$17.1M Buy
128,600
+35,000
+37% +$4.81M ﹤0.01% 2737
2025
Q2
$13.3M Buy
93,600
+40,800
+77% +$5.78M ﹤0.01% 2801
2025
Q1
$8.08M Sell
52,800
-11,100
-17% -$1.74M ﹤0.01% 3277
2024
Q4
$9.56M Buy
+63,900
New +$10M ﹤0.01% 3108
2024
Q2
Sell
-42,500
Closed -$5.87M 9639
2024
Q1
$5.87M Buy
+42,500
New +$5.1M ﹤0.01% 2793
2023
Q4
Sell
-369,600
Closed -$34.9M 9423
2023
Q3
$34.9M Buy
369,600
+320,100
+647% +$32.7M 0.01% 1068
2023
Q2
$4.97M Sell
49,500
-86,900
-64% -$8.06M ﹤0.01% 2599
2023
Q1
$11.1M Buy
136,400
+135,900
+27,180% +$10.9M ﹤0.01% 1815
2022
Q4
$37.3K Sell
500
-178,800
-100% -$13.9M ﹤0.01% 7030
2022
Q3
$14.8M Sell
179,300
-62,600
-26% -$5.49M 0.01% 1477
2022
Q2
$19.3M Buy
241,900
+144,000
+147% +$14.6M 0.01% 1331
2022
Q1
$11.1M Sell
97,900
-4,100
-4% -$460K ﹤0.01% 1866
2021
Q4
$11.6M Buy
102,000
+45,100
+79% +$4.85M ﹤0.01% 2012
2021
Q3
$6.62M Buy
+56,900
New +$7.13M ﹤0.01% 2388
2016
Q1
Sell
-300
Closed -$21K 7738
2015
Q4
$21K Hold
300
﹤0.01% 6706
2015
Q3
$22K Hold
300
﹤0.01% 6605
2015
Q2
$24K Hold
300
﹤0.01% 6700
2015
Q1
$24K Sell
300
-1,800
-86% -$138K ﹤0.01% 6786
2014
Q4
$159K Buy
+2,100
New +$158K ﹤0.01% 5255

Other funds holding DVA

UBS Group's DVA Position: Q1 2026 in Review

UBS Group increased its DaVita (DVA) stake by 106% in Q1 2026, buying an estimated $45.3M and bringing the position to 650,548 shares worth $100M. The position accounts for 0.02% of the portfolio, ranked #1046.

UBS Group first reported a position in DVA in Q4 2014 and has held it in 46 quarters since. The position peaked at $113M in Q4 2024. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • UBS Group held 650,548 shares of DaVita worth $100M as of Q1 2026.
  • UBS Group bought 334,217 DaVita shares in Q1 2026, an estimated $45.3M.
  • DaVita made up 0.02% of UBS Group's portfolio in Q1 2026, its #1046 holding.
  • UBS Group first reported a position in DaVita in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's DaVita position peaked at $113M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.